Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy

References

• Arosio D, Casagrande C. (2016). Advancement in integrin facilitated drug delivery. Adv Drug Deliv Rev 97:111–43.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–51.
   PubMed Web of Science ®Google Scholar
• Chang Y, He L, Li Z, et al. (2017). Designing core-shell gold and selenium nanocomposites for cancer radiochemotherapy. ACS Nano 11:4848–58.
   PubMed Web of Science ®Google Scholar
• Chen T, Liu Y, Zheng WJ, et al. (2010). Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells. Inorg Chem 49:6366–8.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Shi J. (2014). Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells. Mol Pharmaceutics 11:2495–510.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shi J. (2016). Chemistry of mesoporous organosilica in nanotechnology: molecularly organic-inorganic hybridization into frameworks. Adv Mater 28:3235–72.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Al Zaki A, Hui JZ, et al. (2012). Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903–10.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Preat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46.
   PubMed Web of Science ®Google Scholar
• Devanand Venkatasubbu G, Ramasamy S, Ramakrishnan V, Kumar J. (2013). Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery. Adv Powder Technol 24:947–54.
   Web of Science ®Google Scholar
• Guo X, Wei X, Jing Y, Zhou S. (2015). Size changeable nanocarriers with nuclear targeting for effectively overcoming multidrug resistance in cancer therapy. Adv Mater 27:6450–6.
   PubMed Web of Science ®Google Scholar
• Hansen MF, Greibe E, Skovbjerg S, et al. (2015). Folic acid mediates activation of the pro-oncogene STAT3 via the folate receptor alpha. Cell Signal 27:1356–68.
   PubMed Web of Science ®Google Scholar
• He L, Chen T, You Y, et al. (2014a). A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex. Angew Chem Int Ed Engl 53:12532–6.
   PubMed Web of Science ®Google Scholar
• He L, Huang Y, Zhu H, et al. (2014b). Cancer-targeted monodisperse mesoporous silica nanoparticles as carrier of ruthenium polypyridyl complexes to enhance theranostic effects. Adv Funct Mater 24:2754–63.
   Web of Science ®Google Scholar
• He L, Lai H, Chen T. (2015). Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways. Biomaterials 51:30–42.
   PubMed Web of Science ®Google Scholar
• He Q, Shi J. (2014). MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater 26:391–411.
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. (2013). Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714–26.
   PubMed Web of Science ®Google Scholar
• Hu H, You Y, He L, Chen T. (2015). The rational design of NAMI-A-loaded mesoporous silica nanoparticles as antiangiogenic nanosystems. J Mater Chem B 3:6338–46.
   PubMed Web of Science ®Google Scholar
• Huang Y, Huang W, Chan L, et al. (2016). A multifunctional DNA origami as carrier of metal complexes to achieve enhanced tumoral delivery and nullified systemic toxicity. Biomaterials 103:183–96.
   PubMed Web of Science ®Google Scholar
• Huo S, Ma H, Huang K, et al. (2013). Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res 73:319–30.
   PubMed Web of Science ®Google Scholar
• Jiang WT, Fu YT, Yang F, et al. (2014). Gracilaria iemaneiformis polysaccharide as integrin-targeting surface decorator of selenium nanoparticles to achieve enhanced anticancer efficacy. ACS Appl Mater Interfaces 6:13738–48.
   PubMed Web of Science ®Google Scholar
• Karimian A, Ahmadi Y, Yousefi B. (2016). Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst) 42:63–71.
   PubMed Web of Science ®Google Scholar
• Kathawala RJ, Gupta P, Ashby CR Jr, Chen ZS. (2015). The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17.
   PubMed Web of Science ®Google Scholar
• Kiraz Y, Adan A, Kartal Yandim M, Baran Y. (2016). Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biol 37:8471–86.
   PubMed Web of Science ®Google Scholar
• Larsen EK, Nielsen T, Wittenborn T, et al. (2009). Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 3:1947–51.
   PubMed Web of Science ®Google Scholar
• Li R, Wu R, Zhao L, et al. (2010). P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nano 4:1399–408.
   PubMed Web of Science ®Google Scholar
• Li T, Li F, Xiang W, et al. (2016). Selenium-containing amphiphiles reduced and stabilized gold nanoparticles: kill cancer cells via reactive oxygen species. ACS Appl Mater Interfaces 8:22106–12.
   PubMed Web of Science ®Google Scholar
• Liu J, Luo Z, Zhang J, et al. (2016). Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy. Biomaterials 83:51–65.
   PubMed Web of Science ®Google Scholar
• Locher KP. (2016). Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol 23:487–93.
   PubMed Web of Science ®Google Scholar
• Lu Y, Low PS. (2002). Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54:675–93.
   PubMed Web of Science ®Google Scholar
• Luo Z, Ding X, Hu Y, et al. (2013). Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. ACS Nano 7:10271–84.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92.
   PubMed Web of Science ®Google Scholar
• Mekaru H, Lu J, Tamanoi F. (2015). Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev 95:40–9.
   PubMed Web of Science ®Google Scholar
• Meng H, Mai WX, Zhang H, et al. (2013). Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 7:994–1005.
   PubMed Web of Science ®Google Scholar
• Mo J, He L, Ma B, Chen T. (2016). Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier. ACS Appl Mater Interfaces 8:6811–25.
   PubMed Web of Science ®Google Scholar
• Morad SA, Cabot MC. (2013). Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13:51–65.
   PubMed Web of Science ®Google Scholar
• Pan L, He Q, Liu J, et al. (2012). Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc 134:5722–5.
   PubMed Web of Science ®Google Scholar
• Pan L, Liu J, He Q, et al. (2013). Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34:2719–30.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech 2:751–60.
   PubMed Web of Science ®Google Scholar
• Shen D, Yang J, Li X, et al. (2014). Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett 14:923–32.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37.
   PubMed Web of Science ®Google Scholar
• Song GS, Chen YY, Liang C, et al. (2016). Catalase-loaded TaOx nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy. Adv Mater 28:7143–8.
   PubMed Web of Science ®Google Scholar
• Talelli M, Barz M, Rijcken CJ, et al. (2015). Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation. Nano Today 10:93–117.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Wang N, Feng Y, Zeng L, et al. (2015). Functionalized multiwalled carbon nanotubes as carriers of ruthenium complexes to antagonize cancer multidrug resistance and radioresistance. ACS Appl Mater Interfaces 7:14933–45.
   PubMed Web of Science ®Google Scholar
• Wu M, Meng Q, Chen Y, et al. (2016). Large pore-sized hollow mesoporous organosilica for redox-responsive gene delivery and synergistic cancer chemotherapy. Adv Mater 28:1963–9.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, et al. (2014). Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett 347:159–66.
   PubMed Web of Science ®Google Scholar
• Wu SH, Mou CY, Lin HP. (2013). Synthesis of mesoporous silica nanoparticles. Chem Soc Rev 42:3862–75.
   PubMed Web of Science ®Google Scholar
• You Y, Hu H, He L, Chen T. (2015). Differential effects of polymer-surface decoration on drug delivery, cellular retention, and action mechanisms of functionalized mesoporous silica nanoparticles. Chem Asian J 10:2744–54.
   PubMed Web of Science ®Google Scholar
• Yu M, Zheng J. (2015). Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano 9:6655–74.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang X, Li PZ, et al. (2014). Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo. Adv Funct Mater 24:2450–61.
   Web of Science ®Google Scholar